Welcome to Nutraceuticals World   
Jan/Feb 2015 Issue
Last Updated Saturday, February 28 2015

Decas Botanical Synergies

Published January 6, 2010
Decas Botanical Synergies, Carver, MA, has obtained approval from the Korean Food and Drug Administration (KFDA) for use of a health claim supporting urinary health on its PACran, proanthocyanidin (PAC) standardized cranberry powder. The approval process for PACran took nearly two years to complete and was obtained after the company and its Korean partner, Monature, submitted a complete clinical dossier that included required safety data.

Receive free Nutraceuticals World emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Nutraceuticals World On